SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
266 hedge funds and large institutions have $4.04B invested in Sage Therapeutics in 2019 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 103 increasing their positions, 67 reducing their positions, and 73 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 63 | Existing positions closed: 73
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
51% less capital invested
Capital invested by funds: $8.18B → $4.04B (-$4.14B)
Holders
266
Holding in Top 10
5
Calls
$139M
Puts
$99.4M
Top Buyers
| 1 | +$57.5M | |
| 2 | +$44.6M | |
| 3 | +$43.7M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$33.6M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$28.8M |
Top Sellers
| 1 | -$174M | |
| 2 | -$131M | |
| 3 | -$73.2M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$67.4M |
| 5 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
-$56.2M |